About This Calculator

The Heparin Bolus and Infusion Dose Calculator is a clinical support tool designed to simplify the application of weight-based heparin nomograms. It helps clinicians determine appropriate initial and adjusted intravenous (IV) heparin doses to achieve and maintain therapeutic anticoagulation for various indications, such as Venous Thromboembolism (VTE) and Acute Coronary Syndromes (ACS).

Outputs

Based on the selected protocol and patient data, the calculator provides the following key outputs:

• Initial Dose: A one-time IV bolus dose in total units and a starting continuous infusion rate in both units per hour (units/hr) and milliliters per hour (mL/hr).
• Dose Adjustment: Specific actions based on a patient’s activated Partial Thromboplastin Time (aPTT) lab result. This may include a new bolus dose, a change in the infusion rate, or instructions to temporarily hold the infusion.
• Next Steps: A reminder for when to recheck the aPTT after an adjustment, ensuring timely follow-up.

How to Use

Follow these steps to calculate a heparin dose:

1. Select Clinical Protocol: Choose the indication that matches the patient’s condition (e.g., VTE, ACS/MI, Stroke).
2. Enter Heparin Concentration: Select the concentration of the IV heparin bag being used (e.g., 25,000 units in 250 mL).
3. Input Patient Weight: Enter the patient’s weight and specify the unit (kg or lbs). The tool will note if the weight exceeds the protocol’s maximum dosing weight.
4. Choose Calculation Mode: Select ‘Initial Dose’ for new infusions or ‘Dose Adjustment’ for existing infusions based on a new aPTT result.
5. Enter Adjustment Data (if applicable): If adjusting, input the most recent aPTT result and the current infusion rate in units/hr.

Dosing Overview

Intravenous unfractionated heparin (UFH) dosing is guided by institution-specific nomograms that standardize dose adjustments based on weight and aPTT values. The goal is to reach a therapeutic aPTT range quickly and safely. This calculator is based on common protocols, but always defer to your local institution’s guidelines.

Switching Anticoagulants

Switching between anticoagulants requires careful timing to balance thrombotic and bleeding risks.

• To an Oral Anticoagulant (e.g., Warfarin): Overlap of the UFH infusion and oral warfarin is typically required for several days until the INR is therapeutic, at which point the infusion can be stopped.
• From Low-Molecular-Weight Heparin (LMWH): The UFH infusion can usually be started 12-24 hours after the last LMWH dose, depending on the LMWH agent and dosing schedule.

Managing Infusion Interruptions

A continuous heparin infusion may be temporarily stopped for procedures or other reasons.

• Short Interruptions (< 1 hour): The infusion can often be resumed at the same rate without a new bolus, but clinical judgment is required.
• Longer Interruptions: If the infusion is held for an extended period, the aPTT should be rechecked 6 hours after restarting. A clinician may decide to administer a new bolus dose.

Safety Alerts

• High-Alert Medication: Heparin carries a high risk of patient harm if used in error. All dose calculations and pump programming should be independently double-checked by a second clinician.
• Bleeding Risk: The primary complication is bleeding. Monitor patients for signs of bleeding and check baseline and serial hemoglobin/hematocrit.
• Heparin-Induced Thrombocytopenia (HIT): A serious, immune-mediated complication. Monitor platelet counts closely, especially between days 4-14 of therapy.
• Antidote: The reversal agent for heparin is protamine sulfate.

Frequently Asked Questions (FAQ)

Why is a patient’s weight capped for heparin dosing?
Heparin distributes in the plasma, not fat tissue. Capping the weight in obese patients helps prevent excessive dosing and reduces the risk of bleeding.

Why are there different protocols for VTE, ACS, and Stroke?
Different conditions carry different risks of thrombosis and bleeding. Protocols are tailored with different intensity targets (bolus doses, infusion rates, and aPTT ranges) to optimize safety and efficacy for each indication.

How often should the aPTT be monitored?
Typically, an aPTT is checked 6 hours after initiation and 6 hours after any dose adjustment. Once two consecutive therapeutic aPTTs are achieved, monitoring may be extended to once daily.

What should I do if the aPTT result is critically high?
Protocols generally instruct to hold the infusion for 1 hour and decrease the rate. The patient should be assessed for any signs of bleeding.

Can I use this calculator for patients with renal failure?
Unfractionated heparin is not cleared by the kidneys and is often the preferred anticoagulant in severe renal impairment. However, these patients may have other coagulopathies, so close monitoring is essential.

Is this calculator suitable for pediatric patients?
No. This tool is based on adult dosing nomograms and should not be used for pediatric patients, who require specialized protocols.

Is this tool a substitute for my hospital’s approved heparin protocol?
Absolutely not. This calculator is for educational and illustrative purposes only. Always use the official, approved nomograms and protocols of your institution.

What baseline labs are needed before starting a heparin infusion?
A complete blood count (CBC) with platelet count, a baseline aPTT, and prothrombin time (PT/INR) are required.

References

1. Heparin Sodium Injection Prescribing Information. U.S. Food and Drug Administration (FDA). Accessed via Drugs@FDA.
2. Stevens SM, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608.
3. Amsterdam EA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. Circulation. 2014;130(25):e344-e426.
4. Raschke RA, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med. 1993;119(9):874-81.